Research article · 15 Apr 2026
Conference abstractPublished 26 Jun 2014
WRN- Warfarin related nephropathy in human and experimental animals
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
W e have recently identified a new clinical syndrome in patients receiving warfarin for anticoagulation therapy. This syndrome has been named warfarin-related nephropathy (WRN), and patients with chronic kidney disease (CKD) appear to be particularly susceptible. WRN is defined as an acute increase in INR to greater than 3.0, followed by evidence of acute kidney injury (AKI) within a week of the INR increase, defined as a sustained increase in serum creatinine (SCr) of greater than or equal to 0.3 mg/dl. The AKI cannot be explained by any other factors, and the kidney biopsy demonstrates extensive glomerular hemorrhage with tubular obstruction by red blood cells. Beyond AKI, WRN is a significant risk factor for mortality within the first two months of diagnosis, and appears to accelerate the progression of CKD. Recent findings suggest that WRN-like syndromes are not confined to anticoagulation with warfarin, but may be seen with the newer anticoagulants coming into clinical use, such as dabigatran. We had demonstrated that morphologic and laboratory features of WRN can be reproduced in 5/6 nephrectomy model of CKD. Excessive anticoagulation with either warfarin or dabigatran results in serum creatinine elevation, tubular red blood cell casts and acute tubular injury in 5/6 nephrectomy, but not control rats. Possible pathogenesis of WRN may include the PAR-1/thrombomodulin/activated protein C system. Oxidative stress plays a significant role in acute tubular injury, but not glomerular hemorrhage. We suggest that patients on anticoagulant therapy are at high risk to develop AKI and they should be carefully monitored for changes in kidney function
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Sergey V Brodsky”
